Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PSORIASIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00845481
What this trial is testing

A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 24
Early research (Phase 1)Study completedNCT02605057
What this trial is testing

Dermatopharmacokinetic Trial of LEO 80185 Gel

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 32
Large-scale testing (Phase 3)Study completedNCT04632927
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 119
Early research (Phase 1)Study completedNCT03073213
What this trial is testing

Ixekizumab in Chinese Participants With Psoriasis Vulgaris

Who this might be right for
Psoriasis
Eli Lilly and Company 32
Early research (Phase 1)Looking for participantsNCT07024602
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Ascletis Pharma (China) Co., Limited 94
Large-scale testing (Phase 3)Ended earlyNCT05623345
What this trial is testing

Psoriatic Arthritis Study of Izokibep

Who this might be right for
Psoriatic Arthritis
ACELYRIN Inc. 351
Post-approval studies (Phase 4)Ended earlyNCT00953329
What this trial is testing

Alefacept in Subjects With Chronic Plaque Psoriasis Who Failed to Respond to Anti-TNF Therapy

Who this might be right for
Chronic Plaque Psoriasis
John Murray 1
Large-scale testing (Phase 3)Study completedNCT03721172
What this trial is testing

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Who this might be right for
Psoriasis
Amgen 595
Testing effectiveness (Phase 2)Study completedNCT04246372
What this trial is testing

Tofacitinib for Immune Skin Conditions in Down Syndrome

Who this might be right for
Down SyndromeAlopecia AreataAtopic Dermatitis / Eczema+3 more
University of Colorado, Denver 47
Post-approval studies (Phase 4)Study completedNCT02187172
What this trial is testing

Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)

Who this might be right for
PsoriasisCardiovascular Disease
University of Pennsylvania 43
Testing effectiveness (Phase 2)Study completedNCT02173301
What this trial is testing

Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Dr. Reddy's Laboratories Limited 200
Not applicableStudy completedNCT02470481
What this trial is testing

A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics

Who this might be right for
Psoriatic Arthritis
Janssen Research & Development, LLC 250
Not applicableStudy completedNCT00710489
What this trial is testing

Potential Research Study Participant Registry

Who this might be right for
AcneActinic KeratosisDysplastic Nevi+7 more
University of California, Davis 265
Post-approval studies (Phase 4)Study completedNCT00312026
What this trial is testing

Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

Who this might be right for
Psoriasis
Genentech, Inc. 75
Not applicableStudy completedNCT06676176
What this trial is testing

Psoriatic Arthritis Pathobiology and Its Relationship With Clinical Disease Activity

Who this might be right for
Arthritis, Psoriatic
Barts & The London NHS Trust 29
Testing effectiveness (Phase 2)Study completedNCT03832738
What this trial is testing

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 152
Not applicableStudy completedNCT01768858
What this trial is testing

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+3 more
AbbVie 96
Early research (Phase 1)Study completedNCT00220025
What this trial is testing

Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.

Who this might be right for
Psoriasis Vulgaris
Mary Sullivan-Whalen 70
Large-scale testing (Phase 3)Study completedNCT01406938
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 967
Post-approval studies (Phase 4)UnknownNCT04622033
What this trial is testing

Brodalumab in Palmoplantar Psoriasis

Who this might be right for
Palmoplantar Psoriasis
First OC Dermatology 10
Next Page